Opendata, web and dolomites

RESSTORE

REgenerative Stem cell therapy for STroke in Europe

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 RESSTORE project word cloud

Explore the words cloud of the RESSTORE project. It provides you a very rough idea of what is the project "RESSTORE" about.

therapy    republic    trial    options    regenerative    discovery    cover    gmp    cells    efficacy    morbidities    additionally    economics    pilot    therapeutic    public    explore    restoring    kingdom    reference    animal    world    france    mesenchymal    evidences    secondary    functional    blood    cell    clinically    predictive    infusion    united    fatal    allogenic    adipose    time    silico    attractiveness    life    safety    mechanism    population    sme    stroke    societal    contribution    simulations    admscs    first    surely    400    plan    communication    quality    motor    spain    intensive    intravenous    health    full    finland    co    death    workforce    iib    cognitive    effectiveness    monitored    randomised    location    chain    capacities    economic    disability    brain    rating    czech    effect    biomarkers    building    biobanking    enhanced    preclinical    families    competitiveness    resstore    innovative    tissue    treatment    ancillary    stem    underlying    multicentre    mechanisms    complementary    rehabilitation    impairments    patients    mri    trained    private    recovery    context    multimodal    scales    diseases    clinical   

Project "RESSTORE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE GRENOBLE ALPES 

There are not information about this coordinator. Please contact Fabio for more information, thanks.

 Coordinator Country France [FR]
 Project website http://www.resstore.eu
 Total cost 6˙338˙260 €
 EC max contribution 6˙338˙259 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-PHC-2015-single-stage_RTD
 Funding Scheme RIA
 Starting year 2015
 Duration (year-month-day) from 2015-09-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE GRENOBLE ALPES FR (SAINT MARTIN D'HERES) coordinator 1˙781˙937.00
2    UNIVERSITE JOSEPH FOURIER GRENOBLE 1 FR (GRENOBLE) coordinator 0.00
3    OY MEDFILES LTD FI (KUOPIO) participant 802˙187.00
4    ETABLISSEMENT FRANCAIS DU SANG FR (LA PLAINE SAINT DENIS) participant 799˙718.00
5    SERVICIO ANDALUZ DE SALUD ES (SEVILLA) participant 446˙825.00
6    TAMPEREEN KORKEAKOULUSAATIO SR FI (TAMPERE) participant 360˙791.00
7    FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES (BARCELONA) participant 350˙000.00
8    HISTOCELL SL ES (DERIO BIZKAIA) participant 327˙365.00
9    NOVADISCOVERY FR (LYON) participant 274˙375.00
10    FINOVATIS FR (LYON) participant 232˙000.00
11    ASSOCIATION GROUPE ESSEC FR (CERGY PONTOISE CEDEX) participant 200˙000.00
12    ITA-SUOMEN YLIOPISTO FI (KUOPIO) participant 185˙035.00
13    CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE FR (LA TRONCHE) participant 182˙700.00
14    SERVICIO MADRILENO DE SALUD ES (MADRID) participant 134˙600.00
15    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 130˙325.00
16    HOSPICES CIVILS DE LYON FR (LYON) participant 70˙000.00
17    FAKULTNI NEMOCNICE U SV. ANNY V BRNE CZ (Brno) participant 20˙000.00
18    UNIVERSITY OF GLASGOW UK (GLASGOW) participant 20˙000.00
19    ASSISTANCE PUBLIQUE HOPITAUX DE PARIS FR (PARIS) participant 1˙700.00
20    CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON FR (BESANCON CEDEX) participant 1˙700.00
21    CENTRE HOSPITALIER SAINTE ANNE DE PARIS FR (PARIS CEDEX 14) participant 1˙700.00
22    CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE FR (TOULOUSE CEDEX 3) participant 1˙700.00
23    CHU COTE DE NACRE - CAEN FR (CAEN CEDEX 5) participant 1˙700.00
24    CHU HOPITAUX DE BORDEAUX FR (TALENCE) participant 1˙700.00
25    FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA ES (GIRONA) participant 1˙700.00
26    FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU ES (BARCELONA) participant 1˙700.00
27    FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON ES (SORIA) participant 1˙700.00
28    PIRKANMAA HOSPITAL DISTRICT FI (TAMPERE) participant 1˙700.00
29    SERVICIO DE SALUD DE CASTILLA LA MANCHA ES (TOLEDO) participant 1˙700.00
30    SERVIZO GALEGO DE SAUDE ES (Santiago de Compostela) participant 1˙700.00
31    TAMPEREEN YLIOPISTO FI (TAMPERE) participant 0.00

Map

 Project objective

Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and cognitive impairments, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke recovery and patients quality of life. RESSTORE European multicentre randomised phase IIb will explore, for the first time, the efficacy (functional recovery) and safety of intravenous infusion of allogenic adipose tissue derived mesenchymal stem cells (ADMSCs) in 400 stroke patients. Therapeutic effects of ADMSCs will be assessed and monitored in patients using clinical rating scales, multimodal MRI and novel blood biomarkers. Additionally, the societal value and cost-effectiveness of ADMSCs-based regenerative therapy will be evaluated through health economics and predictive in silico simulations. Complementary ancillary animal studies will support the clinical trial by defining i) if the treatment response can be further enhanced by intensive rehabilitation, ii) the contribution of co-morbidities and iii) the mechanism(s) underlying the therapeutic effect. The European regenerative therapy capacities (France, Spain, Finland, United Kingdom and Czech Republic), developed in RESSTORE will cover the full value chain in the field (large scale GMP cell production, clinical testing, biomarkers discovery, understanding of the restoring mechanisms, modelling, biobanking, economic studies, exploitation and communication plan). RESSTORE will thus surely contribute, together with the workforce trained in the context of the programme, to improve its public and private (SME) competitiveness and increase the attractiveness of Europe as a reference location to develop and clinically assess new innovative therapeutic options for brain diseases.

 Deliverables

List of deliverables.
RESSTORE Website Websites, patent fillings, videos etc. 2019-10-31 10:22:32
Agencies and Ethics Approvals Documents, reports 2019-10-31 10:22:31
Registration of the clinical trial Websites, patent fillings, videos etc. 2019-10-31 10:22:31

Take a look to the deliverables list in detail:  detailed list of RESSTORE deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Lili Cui, Anaïck Moisan, Jukka Jolkkonen
Intravascular cell therapy in stroke: predicting the future trends
published pages: 63-68, ISSN: 1746-0751, DOI: 10.2217/rme-2018-0037
Regenerative Medicine 14/1 2019-10-31
2018 Olivier Detante, Jérémy Papassin
Thérapie cellulaire
published pages: 621-631, ISSN: , DOI:
Accident vasculaire cérebraux - Thérapeutique 2019-10-31
2017 Olivier Detante, Keith Muir, Jukka Jolkkonen
Cell Therapy in Stroke—Cautious Steps Towards a Clinical Treatment
published pages: , ISSN: 1868-4483, DOI: 10.1007/s12975-017-0587-6
Translational Stroke Research 2019-10-31
2015 Renard, F. Urvoy, M. Jaillard, A.
Bayesian stroke lesion estimation for automatic registration of DTI image
published pages: 8, ISSN: , DOI:
MICCAI 2019-10-31
2015 Renard, F. Urvoy, M. Jaillard, A.
Bayesian stroke lesion estimation for automatic registration of DTI image
published pages: 8, ISSN: , DOI:
MICCAI 2019-10-31
2016 Marc Hommel, Olivier Detante, Isabelle Favre, Emmanuel Touzé, Assia Jaillard
How to Measure Recovery? Revisiting Concepts and Methods for Stroke Studies
published pages: , ISSN: 1868-4483, DOI: 10.1007/s12975-016-0488-0
Translational Stroke Research 2019-10-31

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RESSTORE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "RESSTORE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

INADVANCE (2019)

Patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard

Read More